Reuters logo
BRIEF-Crispr Therapeutics, Intellia Therapeutics, Caribou Biosciences and Ers Genomics announce global agreement
December 16, 2016 / 1:55 PM / 9 months ago

BRIEF-Crispr Therapeutics, Intellia Therapeutics, Caribou Biosciences and Ers Genomics announce global agreement

Dec 16 (Reuters) - Crispr Therapeutics Ag -

* Crispr Therapeutics, Intellia Therapeutics, Caribou Biosciences and Ers Genomics announce global agreement on the foundational intellectual property for CRISPR/Cas9 gene editing technology

* Parties commit to maintain and coordinate prosecution, defense and enforcement of CRISPR/Cas9 foundational patent portfolio worldwide Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below